| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2515 | 2020 |
| A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) CC Bleul, RC Fuhlbrigge, JM Casasnovas, A Aiuti, TA Springer The Journal of experimental medicine 184 (3), 1101-1109, 1996 | 1932 | 1996 |
| The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to … A Aiuti, IJ Webb, C Bleul, T Springer, JC Gutierrez-Ramos The Journal of experimental medicine 185 (1), 111-120, 1997 | 1779 | 1997 |
| Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning A Aiuti, S Slavin, M Aker, F Ficara, S Deola, A Mortellaro, S Morecki, ... Science 296 (5577), 2410-2413, 2002 | 1435 | 2002 |
| Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy A Biffi, E Montini, L Lorioli, M Cesani, F Fumagalli, T Plati, C Baldoli, ... Science 341 (6148), 1233158, 2013 | 1356 | 2013 |
| Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome A Aiuti, L Biasco, S Scaramuzza, F Ferrua, MP Cicalese, C Baricordi, ... Science 341 (6148), 1233151, 2013 | 1239 | 2013 |
| Gene therapy for immunodeficiency due to adenosine deaminase deficiency A Aiuti, F Cattaneo, S Galimberti, U Benninghoff, B Cassani, L Callegaro, ... New England Journal of Medicine 360 (5), 447-458, 2009 | 1152 | 2009 |
| Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial M Sessa, L Lorioli, F Fumagalli, S Acquati, D Redaelli, C Baldoli, ... The Lancet 388 (10043), 476-487, 2016 | 479 | 2016 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 456 | 2021 |
| Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase δ syndrome: the european society for immunodeficiencies-activated phosphoinositide 3-kinase δ … ME Maccari, H Abolhassani, A Aghamohammadi, A Aiuti, O Aleinikova, ... Frontiers in immunology 9, 543, 2018 | 352 | 2018 |
| Coronavirus disease 2019 in patients with inborn errors of immunity: an international study I Meyts, G Bucciol, I Quinti, B Neven, A Fischer, E Seoane, ... Journal of Allergy and Clinical Immunology 147 (2), 520-531, 2021 | 345 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 342 | 2021 |
| Hot spots of retroviral integration in human CD34+ hematopoietic cells C Cattoglio, G Facchini, D Sartori, A Antonelli, A Miccio, B Cassani, ... Blood, The Journal of the American Society of Hematology 110 (6), 1770-1778, 2007 | 336 | 2007 |
| A map of human circular RNAs in clinically relevant tissues PG Maass, P Glažar, S Memczak, G Dittmar, I Hollfinger, L Schreyer, ... Journal of molecular medicine 95, 1179-1189, 2017 | 322 | 2017 |
| Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy A Aiuti, B Cassani, G Andolfi, M Mirolo, L Biasco, A Recchia, F Urbinati, ... The Journal of clinical investigation 117 (8), 2233-2240, 2007 | 311 | 2007 |
| Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy … A Aiuti, MG Roncarolo, L Naldini EMBO molecular medicine 9 (6), 737-740, 2017 | 305 | 2017 |
| Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders A Stray-Pedersen, HS Sorte, P Samarakoon, T Gambin, IK Chinn, ... Journal of Allergy and Clinical Immunology 139 (1), 232-245, 2017 | 283 | 2017 |
| Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome M Bosticardo, F Marangoni, A Aiuti, A Villa, M Grazia Roncarolo Blood, The Journal of the American Society of Hematology 113 (25), 6288-6295, 2009 | 274 | 2009 |
| Expression of CXCR4, the receptor for stromal cell‐derived factor‐1 on fetal and adult human lymphohematopoietic progenitors A Aiuti, M Tavian, A Cipponi, F Ficara, E Zappone, J Hoxie, B Peault, ... European journal of immunology 29 (6), 1823-1831, 1999 | 271 | 1999 |
| Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study F Barzaghi, LCA Hernandez, B Neven, S Ricci, ZY Kucuk, JJ Bleesing, ... Journal of Allergy and Clinical Immunology 141 (3), 1036-1049. e5, 2018 | 259 | 2018 |
